[Other] KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study |
|
This post will be closed automatically in 2026-06-25 14:30
Reward10points
|
| |
post
reply
points
3520
10
Dreams Turned into Nightmares: Reimagining the American Dream in John Steinbeck’sOf Mice and Men
10
High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients
20
Factor Allocation Model: Integrating Factor Models and Strategies into the Asset Allocation Process
20
Polymer-based nanoparticles for drug delivery systems and cancer therapeutics.
20
Paper Colonialism: Instructions and Institutions at the Royal Botanic Gardens, Kew, 1770–1820
